False Choice: Drug Price Reductions Won’t Undermine Innovation, Bentley Researchers Argue

 
• By Cathy Kelly
  
Paper brings focus on how price controls impact small biotechs. • Source: Alamy

More from Pricing Debate

More from Market Access